Form 4: Synopsys CEO Sassine Ghazi Executes Stock Options and Sells Shares
SEC Form 4 Filing
Synopsys CEO Sassine Ghazi exercised stock options and sold shares on March 3, 2025, according to a Form 4 filing with the SEC.
Summary
- On February 28, 2025, Sassine Ghazi acquired 25 shares of Synopsys common stock at $388.688 per share through the Employee Stock Purchase Plan.
- On March 3, 2025, Ghazi exercised options to acquire 11,366 shares of Synopsys common stock at an exercise price of $89.76.
- Also on March 3, 2025, Ghazi sold 11,366 shares at a weighted average price of $463.7488, with prices ranging from $461.79 to $466.20.
- Following these transactions, Ghazi directly owns 70,922 shares of Synopsys common stock and 22,732 non-qualified stock options.
Sentiment
Score: 5
Explanation: Neutral sentiment. The document simply reports stock transactions by an executive, which is a routine occurrence. The use of a 10b5-1 plan suggests pre-planned transactions.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting they were planned well in advance.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a common mechanism for executives to sell shares without raising concerns about insider trading.
- The frequency and size of these transactions can vary widely depending on the company and the individual executive's financial situation.
Stakeholder Impact
- Shareholders may be interested in executive stock transactions as an indicator of management's confidence in the company.
- The transactions themselves are unlikely to have a significant impact on the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 12/12/2019 | Date exercisable for non-qualified stock options |
| 09/30/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 02/28/2025 | Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan |
| 03/03/2025 | Exercise of stock options and sale of shares |
| 03/04/2025 | Date of Form 4 filing |
| 12/12/2025 | Expiration date for non-qualified stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.